Cargando…
Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer
[Figure: see text]
Autores principales: | Chang, Jie, Yang, Ruirui, Chen, Lifan, Fan, Zisheng, Zhou, Jingyi, Guo, Hao, Zhang, Yinghui, Liu, Yadan, Zhou, Guizhen, Zhang, Keke, Chen, Kaixian, Jiang, Hualiang, Zheng, Mingyue, Zhang, Sulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136604/ https://www.ncbi.nlm.nih.gov/pubmed/35646528 http://dx.doi.org/10.1016/j.apsb.2022.02.011 |
Ejemplares similares
-
Experimental study of the anti-atherosclerotic effect of demethylzeylasteral
por: Huang, Ying, et al.
Publicado: (2017) -
Drug target inference by mining transcriptional data using a novel graph convolutional network framework
por: Zhong, Feisheng, et al.
Publicado: (2021) -
Sequence-based drug design as a concept in computational drug design
por: Chen, Lifan, et al.
Publicado: (2023) -
Pharmacological inhibition of demethylzeylasteral on JAK-STAT signaling ameliorates vitiligo
por: Chang, Yuqian, et al.
Publicado: (2023) -
A hybrid framework for improving uncertainty quantification in deep learning-based QSAR regression modeling
por: Wang, Dingyan, et al.
Publicado: (2021)